Aziyo Biologics Presents Positive Clinical Data on CanGaroo® Biologic Envelope
<!-- Name:DistributionId Value:8842517 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Browsing Tag
Aziyo Biologics
Aziyo Biologics and LeMaitre Vascular Partner for the Distribution of Aziyo’s…
<!-- Name:DistributionId Value:8812515 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Aziyo Biologics to Participate in Upcoming Investor Conferences
SILVER SPRING, Md., Nov. 21, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a biologics company with a portfolio of regenerative products aimed at improving compatibility…
Aziyo Biologics to Present at the Inaugural Gilmartin Group Emerging Growth Company…
SILVER SPRING, Md., Aug. 17, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company, today announced the company will present at…
Aziyo Biologics Announces $25 Million Loan Facility with SWK Holdings
SILVER SPRING, Md., Aug. 10, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO) (the “Company”), a commercial-stage regenerative medicine company announced today that it has…
Aziyo Biologics Appoints Dr. C. Randal Mills as Interim President and CEO
SILVER SPRING, Md., June 21, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of…
Aziyo Biologics to Participate in the Cowen 42nd Annual Health Care Conference
SILVER SPRING, Md., Feb. 23, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of…
Aziyo Biologics to Present at the H.C. Wainwright Bioconnect Virtual Conference
SILVER SPRING, Md., Dec. 27, 2021 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of…
Aziyo Biologics Announces Closing of $14.0 Million Private Placement
SILVER SPRING, Md., Dec. 08, 2021 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (the “Company”), a commercial-stage regenerative medicine company focused on creating the next generation of…